Resnick Joshua

Resnick Joshua is listed in filings as Director at Cidara Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 7, 2026, including 8 public disclosures. Recent filings connect the profile to Cidara Therapeutics, Inc. (CDTX), Sionna Therapeutics, Inc. (SION), PepGen Inc. (PEPG), and Vor Biopharma Inc. (VOR). The current snapshot covers public activity from Jun 21, 2024 to Jan 7, 2026. Reported amounts are shown as $591.0K to $339.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.